Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma following induction therapy: a systematic review of the published literature-Reference-Cited by-同舟云学术

Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma following induction therapy: a systematic review of the published literature

Published:2021-05-21 Issue:1 Volume:74 Page:43-53
ISSN:2038-131X
Container-title:Updates in Surgery
language:en
Short-container-title:Updates Surg

Author:

Zhou Yanming^ORCID,Liao Shan,You Jun,Wu Huaxing

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s13304-021-01089-1.pdf

Reference46 articles.

1. Rahib L, Smith BD, Aizenberg R et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united states. Cancer Res 74:2913–2921. https://doi.org/10.1158/0008-5472.Can-14-0155

2. Mukherjee S, Hurt CN, Bridgewater J et al (2013) Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (scalop): a multicentre, randomised, phase 2 trial. Lancet Oncol 14:317–326. https://doi.org/10.1016/s1470-2045(13)70021-4

3. Conroy T, Desseigne F, Ychou M et al (2011) Folfirinox versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825. https://doi.org/10.1056/NEJMoa1011923

4. Marthey L, Sa-Cunha A, Blanc JF et al (2015) Folfirinox for locally advanced pancreatic adenocarcinoma: results of an ageo multicenter prospective observational cohort. Ann Surg Oncol 22:295–301. https://doi.org/10.1245/s10434-014-3898-9

5. Crippa S, Bittoni A, Sebastiani E et al (2016) Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? Eur J Surg Oncol 42:1533–1539. https://doi.org/10.1016/j.ejso.2016.06.398

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma;World Journal of Gastrointestinal Oncology;2024-03-15

2. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study;British Journal of Surgery;2024-03

3. Pretherapeutic factors predicting conversion surgery in unresectable pancreatic ductal adenocarcinoma: A retrospective study;Oncology Letters;2024-02-22

4. Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy;Cancer Research and Treatment;2024-01-15

5. Real-World Evidence in Localized Pancreatic: Coping with Uncertainty in Unselected Populations;Journal of Cancer Therapy;2024